Skip to main content

Advertisement

SpringerLink
Log in

Late relapse of primary hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation: a consequence of low-level chimerism from a carrier donor?

  • Brief Report
  • Published:
Immunologic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013;2013:605–11.

    Article  PubMed  Google Scholar 

  2. Marsh RA, Vaughn G, Kim MO, Li D, Jodele S, Joshi S, et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood. 2010;116:5824–31.

    Article  CAS  PubMed  Google Scholar 

  3. Hartz B, Marsh R, Rao K, Henter JI, Jordan M, Filipovich L, et al. The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis. Blood. 2016;127:3281–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ouachee-Chardin M, Elie C, de Saint Basile G, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single- center report of 48 patients. Pediatrics. 2006;117:e743–50.

    Article  PubMed  Google Scholar 

  5. Voskoboinik I, Thia M-C, Fletcher J, Ciccone A, Browne K, Smyth MJ, et al. Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain. A critical role for aspartate residues 429, 435, 483 and 485 but not 491. J Biol Chem. 2005;280:8426–34.

    Article  CAS  PubMed  Google Scholar 

  6. House IG, Thia K, Brennan AJ, Tothill R, Dobrovic A, Yeh WZ, et al. Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals. Immunol Cell Biol. 2015;93:575–80.

    Article  CAS  PubMed  Google Scholar 

  7. van Montfrans JM, Rudd E, van de Corput L, Henter JI, Nikkels P, Wulffraat N, et al. Fatal hemophagocytic lymphohistiocytosis in X-linked chronic granulomatous disease associated with a perforin gene variant. Pediatr Blood Cancer. 2009;52:527–9.

    Article  PubMed  Google Scholar 

  8. Vastert SJ, van Wijk R, D’Urbano LE, de Vooght KMK, de Jager W, Ravelli A, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology. 2010;49:441–9.

    Article  CAS  PubMed  Google Scholar 

  9. Ghosh S, Carmo M, Calero-Garcia M, Ricciardelli I, Bustamante Ogando JC, Blundell MP, et al. T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations. J Allergy Clin Immunol. 2018;142:904–913.e3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Amy E. Verrinder and Joanna L. S. Marsden contributed equally to this work.

Authors and Affiliations

  1. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK

    Amy E. Verrinder, Joanna L. S. Marsden, Mary A. Slatter & Andrew R. Gennery

  2. Children’s Haematopoietic Stem Cell Transplant Unit, Great North Children’s Hospital, Newcastle upon Tyne Hospital NHS Foundation Trust, Clinical Resource Building, Floor 4, Block 2, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK

    Mary A. Slatter & Andrew R. Gennery

  3. Department of Radiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

    Leigh McDonald

  4. Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

    Chris M. Bacon & Joaquim Majo

  5. Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK

    Chris M. Bacon

Authors
  1. Amy E. Verrinder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna L. S. Marsden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary A. Slatter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leigh McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chris M. Bacon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joaquim Majo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrew R. Gennery
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew R. Gennery.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verrinder, A.E., Marsden, J.L.S., Slatter, M.A. et al. Late relapse of primary hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation: a consequence of low-level chimerism from a carrier donor?. Immunol Res 67, 261–264 (2019). https://doi.org/10.1007/s12026-019-09085-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-019-09085-9

Search

Navigation